Key result
Adipose tissue-specific deletion of ANGPTL4 in mice improved glucose tolerance, enhanced lipid clearance, and significantly reduced atherosclerotic plaque size compared to wild-type mice.
Adipose tissue-specific deletion of ANGPTL4 improves glucose tolerance and reduces atherosclerosis in mice, highlighting its role in peripheral lipid deposition and cardiometabolic disease.
Answers are grounded in this paper and cite their sources.
Supports adipose ANGPTL4 as a cardiometabolic target; leaves open human translation pending clinical studies.
Alterations in ectopic lipid deposition and circulating lipids are major risk factors for developing cardiometabolic diseases. Angiopoietin-like protein 4 (ANGPTL4), a protein that inhibits lipoprotein lipase (LPL), controls fatty acid (FA) uptake in adipose and oxidative tissues and regulates circulating triacylglycerol-rich (TAG-rich) lipoproteins. Unfortunately, global depletion of ANGPTL4 results in severe metabolic abnormalities, inflammation, and fibrosis when mice are fed a high-fat diet (HFD), limiting our understanding of the contribution of ANGPTL4 in metabolic disorders. Here, we demonstrate that genetic ablation of ANGPTL4 in adipose tissue (AT) results in enhanced LPL activity, rapid clearance of circulating TAGs, increased AT lipolysis and FA oxidation, and decreased FA synthesis in AT. Most importantly, we found that absence of ANGPTL4 in AT prevents excessive ectopic lipid deposition in the liver and muscle, reducing novel PKC (nPKC) membrane translocation and enhancing insulin signaling. As a result, we observed a remarkable improvement in glucose tolerance in short-term HFD-fed AT-specific Angptl4-KO mice. Finally, lack of ANGPTL4 in AT enhances the clearance of proatherogenic lipoproteins, attenuates inflammation, and reduces atherosclerosis. Together, these findings uncovered an essential role of AT ANGPTL4 in regulating peripheral lipid deposition, influencing whole-body lipid and glucose metabolism and the progression of atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Aryal et al. (2018) studied Atherosclerosis and metabolic disorders. Adipose tissue-specific ANGPTL4 knockout vs. Wild-type mice was evaluated on Atherosclerotic plaque size and glucose tolerance. Adipose tissue-specific deletion of ANGPTL4 in mice improved glucose tolerance, enhanced lipid clearance, and significantly reduced atherosclerotic plaque size compared to wild-type mice.
Synapse has enriched 10 related papers. Consider them for comparative context: